ANGIOTECH PHARMACEUTICALS INC — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$243.8M

Net Income/Loss (FY2012)

-$6.2M

Total Assets (FY2012)

$608.4M

Total Equity (FY2012)

$140.7M

Cash Flows from Operating Activities (FY2012)

$66.4M

Source: ANGIOTECH PHARMACEUTICALS INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.